Study to Evaluate the Immune Response After Booster Vaccination with Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa

Trial Identifier: TD500056
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: January 2021
Primary Completion Date: January 2023
Study Completion Date: January 2023
Condition: Diphtheria Immunisation; Pertussis Immunisation; Polio Immunisation; Tetanus Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
SOUTH AFRICA Cape Town, SOUTH AFRICA, 7925
SOUTH AFRICA Johannesburg, SOUTH AFRICA, 1619
SOUTH AFRICA MIDDELBURG, SOUTH AFRICA, 1055